← Open Payments lookup

MICHELLE EVANS: Open Payments

NPI 1760104178 · VIENNA, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$457 in 21 payments from 11 companies in 2025. Trend: 2023 $742 · 2024 $494 · 2025 $457

Food & beverage: $441Education: $16
CompanyPaymentsAmount
Novo Nordisk Inc6$115
Lilly USA, LLC3$72
Amgen Inc.2$47
Dexcom, Inc.1$42
Amneal Pharmaceuticals LLC2$42
ABBVIE INC.2$37
Takeda Pharmaceuticals U.S.A., Inc.1$24
Boehringer Ingelheim Pharmaceuticals, Inc.1$22
Novartis Pharmaceuticals Corporation1$22
Insulet Corporation1$20

Products named: MOUNJARO, Wegovy, Ozempic, DEXCOM G7 GSS (161), UNITHROID, TEPEZZA, GLASSIA, JARDIANCE.

Industry payments across VA — which companies pay providers there.